MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

October 04, 2012

MSF launched the Patent Opposition Database as part of the campaign to boost access to medicines in countries where patients can't afford the high drug prices some companies seek to preserve.  

September 27, 2012

In this blog post from BMJ Group Blogs, lawyer and India manager of MSF's Access Campaign Leena Menghaney discusses the two legal battles that are taking center stage in the struggle over India's medicines patent law.

September 18, 2012

Dr. Unni Karunakara, international president of Doctors Without Borders/Médecins Sans Frontières (MSF), met yesterday in Geneva with a Bahraini parliamentary delegation that included the Minister of Human Rights Dr. Salah Bin Ali Abdularahman.

Dr. Karunakara raised issues related to the need for impartial access to health care in Bahrain, and the obligation of medical staff to provide health care regardless of patients’ political or sectarian affiliations.

August 21, 2012

Novartis AG goes to India's Supreme Court on Wednesday to seek patent protection for its blockbuster cancer drug Glivec in a case that could deliver far-reaching ramifications for multinational pharmaceutical companies operating in India.... Novartis's critics, including Médecins Sans Frontières [Doctors Without Borders], say that if the company prevails, it could set a legal precedent that allows pharmaceutical giants to patent a range of drugs in India that are now available from generic producers, including HIV medicines. That would demolish a thriving low-cost industry and lead to higher prices, not just in India, they say, but elsewhere in the developing world where India is a major exporter of drugs.

April 12, 2012

In Bahrain, people continue to avoid seeking medical care in public hospitals for fear of discrimination, harassment, and ill treatment.

March 27, 2012

On July 10, 2012, India's Supreme Court will hear the challenge to the country's patent law by Novartis, a case with enormous ramifications for the production of low-cost generic medications.

March 22, 2012

Multidrug-resistant tuberculosis patient and TB&ME blogger Athong talks from India about the stigma he faces living with the disease. Read Athong's TB&ME blog here.

March 12, 2012

A landmark patent ruling in India could possibly set a precedent that allows patients in developing countries far greater access to essential medicines.

March 02, 2012

MSF's appeal to Novartis to drop its case against India continues as the pharmaceutical company's day in court draws near.

February 14, 2012

Read Novartis's statements on its generic medicines court case, and learn why they're wrong.

Pages

October 04, 2012

MSF launched the Patent Opposition Database as part of the campaign to boost access to medicines in countries where patients can't afford the high drug prices some companies seek to preserve.  

September 27, 2012

In this blog post from BMJ Group Blogs, lawyer and India manager of MSF's Access Campaign Leena Menghaney discusses the two legal battles that are taking center stage in the struggle over India's medicines patent law.

September 18, 2012

Dr. Unni Karunakara, international president of Doctors Without Borders/Médecins Sans Frontières (MSF), met yesterday in Geneva with a Bahraini parliamentary delegation that included the Minister of Human Rights Dr. Salah Bin Ali Abdularahman.

Dr. Karunakara raised issues related to the need for impartial access to health care in Bahrain, and the obligation of medical staff to provide health care regardless of patients’ political or sectarian affiliations.

August 21, 2012

Novartis AG goes to India's Supreme Court on Wednesday to seek patent protection for its blockbuster cancer drug Glivec in a case that could deliver far-reaching ramifications for multinational pharmaceutical companies operating in India.... Novartis's critics, including Médecins Sans Frontières [Doctors Without Borders], say that if the company prevails, it could set a legal precedent that allows pharmaceutical giants to patent a range of drugs in India that are now available from generic producers, including HIV medicines. That would demolish a thriving low-cost industry and lead to higher prices, not just in India, they say, but elsewhere in the developing world where India is a major exporter of drugs.

April 12, 2012

In Bahrain, people continue to avoid seeking medical care in public hospitals for fear of discrimination, harassment, and ill treatment.

March 27, 2012

On July 10, 2012, India's Supreme Court will hear the challenge to the country's patent law by Novartis, a case with enormous ramifications for the production of low-cost generic medications.

March 22, 2012

Multidrug-resistant tuberculosis patient and TB&ME blogger Athong talks from India about the stigma he faces living with the disease. Read Athong's TB&ME blog here.

March 12, 2012

A landmark patent ruling in India could possibly set a precedent that allows patients in developing countries far greater access to essential medicines.

March 02, 2012

MSF's appeal to Novartis to drop its case against India continues as the pharmaceutical company's day in court draws near.

February 14, 2012

Read Novartis's statements on its generic medicines court case, and learn why they're wrong.

Pages